Cargando…

Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe

Immune checkpoint targeting immunotherapy has revolutionized the treatment of certain cancers in the recent years. Determination of the status of immune checkpoint expression in particular cancers may assist decision making. Here, we describe the development of a single-stranded aptamer-based molecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malicki, Stanisław, Pucelik, Barbara, Żyła, Edyta, Benedyk-Machaczka, Małgorzata, Gałan, Wojciech, Golda, Anna, Sochaj-Gregorczyk, Alicja, Kamińska, Marta, Encarnação, João Crispim, Chruścicka, Barbara, Marti, Hans-Peter, Chen, Tony Jialiang, Magiera-Mularz, Katarzyna, Zięba, Bartosz, Holak, Tad A., Dąbrowski, Janusz M., Czarna, Anna, Kozieł, Joanna, Mydel, Piotr, Dubin, Grzegorz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229018/ https://www.ncbi.nlm.nih.gov/pubmed/35745616 http://dx.doi.org/10.3390/ph15060697

Ejemplares similares

Identification and characterization of aptameric inhibitors of human neutrophil elastase
por: Malicki, Stanisław, et al.
Publicado: (2023)

Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor
por: Aliko, Ardita, et al.
Publicado: (2019)

Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
por: Zyla, Edyta, et al.
Publicado: (2021)

Mechanism of MyD88S mediated signal termination
por: Pustelny, Katarzyna, et al.
Publicado: (2022)

DYRK1A inhibitors leucettines and TGF-β inhibitor additively stimulate insulin production in beta cells, organoids, and isolated mouse islets
por: Pucelik, Barbara, et al.
Publicado: (2023)

Competition NMR for Detection of Hit/Lead Inhibitors of Protein–Protein Interactions
por: Musielak, Bogdan, et al.
Publicado: (2020)

Diabetic Kinome Inhibitors—A New Opportunity for β-Cells Restoration
por: Pucelik, Barbara, et al.
Publicado: (2021)

Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein
por: Reyes Romero, Atilio, et al.
Publicado: (2022)

PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action
por: Surmiak, Ewa, et al.
Publicado: (2021)

Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies
por: Chruścicka-Smaga, Barbara, et al.
Publicado: (2023)

Lithocholic Acid Hydroxyamide Destabilizes Cyclin D1 and Induces G(0)/G(1) Arrest by Inhibiting Deubiquitinase USP2a
por: Magiera, Katarzyna, et al.
Publicado: (2017)

CA-170 – A Potent Small-Molecule PD-L1 Inhibitor or Not?
por: Musielak, Bogdan, et al.
Publicado: (2019)

Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape
por: Aliko, Ardita, et al.
Publicado: (2018)

Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics
por: Pustelny, Katarzyna, et al.
Publicado: (2023)

AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model
por: Chen, Tony J., et al.
Publicado: (2021)

DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis
por: Barzowska, Agata, et al.
Publicado: (2021)

Human and mouse PD-L1: similar molecular structure, but different druggability profiles
por: Magiera-Mularz, Katarzyna, et al.
Publicado: (2020)

Exploring the Surface of the Ectodomain of the PD-L1 Immune Checkpoint with Small-Molecule Fragments
por: Kitel, Radoslaw, et al.
Publicado: (2022)

Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1)
por: Zak, Krzysztof M., et al.
Publicado: (2016)

Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune Checkpoint
por: Konieczny, Magdalena, et al.
Publicado: (2020)

Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies
por: Rodriguez, Ismael, et al.
Publicado: (2023)

Development of a novel, high-affinity ssDNA trypsin inhibitor
por: Malicki, Stanislaw, et al.
Publicado: (2019)

Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
por: Shaabani, Shabnam, et al.
Publicado: (2022)

Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein–Protein Interaction
por: Muszak, Damian, et al.
Publicado: (2021)

Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists
por: Butera, Roberto, et al.
Publicado: (2021)

Correction: Serwotka-Suszczak, A. M. et al. A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells. Int. J. Mol. Sci. 2017, 18, 401
por: Serwotka-Suszczak, Anna M., et al.
Publicado: (2018)

A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells
por: Serwotka-Suszczak, Anna M., et al.
Publicado: (2017)

A unique network of attack, defence and competence on the outer membrane of the periodontitis pathogen Tannerella forsythia
por: Książek, Mirosław, et al.
Publicado: (2022)

Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells
por: Skalniak, Lukasz, et al.
Publicado: (2017)

The Link Between Periodontal Disease and Rheumatoid Arthritis: An Updated Review
por: Koziel, Joanna, et al.
Publicado: (2014)

Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies
por: Pucelik, Barbara, et al.
Publicado: (2017)

Correction: Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies
por: Pucelik, Barbara, et al.
Publicado: (2018)

Design and In Vitro Evaluation of a Cytotoxic Conjugate Based on the Anti-HER2 Affibody Fused to the Fc Fragment of IgG1
por: Sochaj-Gregorczyk, Alicja M., et al.
Publicado: (2017)

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors
por: Ważyńska, Marta A., et al.
Publicado: (2023)

Application of Blue Honeysuckle Powder Obtained by an Innovative Method of Low-Temperature Drying in Skincare Face Masks
por: Klimaszewska, Emilia, et al.
Publicado: (2021)

Photodynamic inactivation (PDI) as a promising alternative to current pharmaceuticals for the treatment of resistant microorganisms
por: Pucelik, Barbara, et al.
Publicado: (2022)

Analysis tools for single-monomer measurements of self-assembly processes
por: Hoyer, Maria, et al.
Publicado: (2022)

Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells
por: Damiani, Isabella, et al.
Publicado: (2021)

Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity
por: Chudzian, Julia, et al.
Publicado: (2018)

Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells
por: Skalniak, Lukasz, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eceqq63ascukiq10q8ihksamv7